PODXL and prostate cancer: Podocalyxin (including PODXL1, PODXL2 and PODXL3) induction resulted in altered migration and invasion, increased MMP expression with increased MAPK and PI3K activity through forming a complex with Ezrin protein, in breast and prostate cancer [38].